Skip to main content
    I

    Ironwood Pharmaceuticals Inc (IRWD)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $4.85
    +0.02 (+0.41%)

    Market Cap: $799.61M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Ironwood Pharmaceuticals Inc (IRWD) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Ironwood Pharmaceuticals are Collegium Pharmaceutical (COLL), Amphastar (AMPH) and Phibro Animal Health (PAHC). Ironwood Pharmaceuticals trades at 5.4x earnings, against a median of 12.7x for the 9 of these companies with a P/E. By market cap, Ironwood Pharmaceuticals ranks 9th of the 13 companies on this page; BioCryst Pharmaceuticals (BCRX) is the largest at $1.96B.

    Peer Comparison

    IRWD's ROIC of 70.5% is above the peer median of 8.0%, and its revenue growth of 9.0% is below the median of 9.4%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Ironwood Pharmaceuticals (IRWD)$799.61M5.4x2.0x37.4%70.5%9.0%0.00%
    Collegium Pharmaceutical Inc (COLL)$786.83M3.7x1.0x4.7%8.1%3.3%0.00%
    Amphastar P (AMPH)$1.25B10.3x1.7x13.3%7.9%8.2%0.00%
    Phibro Animal Health Corporation (PAHC)$1.46B10.7x0.9x6.7%11.7%6.3%1.37%
    Pacira BioSciences, Inc. (PCRX)$1.46B20.0x2.0x5.1%4.2%-1.6%0.00%
    Harrow Health Inc (HROW)$1.13BN/A3.6x-9.4%-0.3%38.6%0.00%
    BioCryst Pharmaceuticals Inc (BCRX)$1.96B4.4x2.0x-37.4%24937.1%13.1%0.00%
    Evotec SE ADR (EVO)$561.51MN/A0.7x-25.2%-15.1%0.6%0.00%
    Cronos Group Inc (CRON)$1.24B28.4x5.6x28.0%N/A74.6%0.00%
    Supernus Pharmaceuticals, Inc. (SUPN)$1.52B12.7x2.0x32.8%N/A13.4%0.00%
    Eton Pharmaceuticals Inc (ETON)$1.84B36.7x13.0x35.3%37.0%157.9%0.00%
    Lifecore Biomedical Inc. (LFCR)$243.36MN/AN/A-66.8%N/A-18.6%0.00%
    Kamada (KMDA)$467.05M18.9x2.4x12.7%N/A10.7%2.10%
    Peer median$1.25B12.7x2.0x5.9%8.0%9.4%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Ironwood Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Collegium Pharmaceutical Inc (COLL)
    Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications.
    COLL competitors
    Amphastar P (AMPH)
    Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation...
    AMPH competitors
    Phibro Animal Health Corporation (PAHC)
    Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily...
    PAHC competitors
    Pacira BioSciences, Inc. (PCRX)
    Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United...
    PCRX competitors
    Harrow Health Inc (HROW)
    Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.
    HROW competitors
    BioCryst Pharmaceuticals Inc (BCRX)
    BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
    BCRX competitors
    Evotec SE ADR (EVO)
    Evotec SE is a prominent global biotechnology company headquartered in Hamburg, Germany...
    EVO competitors
    Cronos Group Inc (CRON)
    Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
    CRON competitors
    Supernus Pharmaceuticals, Inc. (SUPN)
    Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of diseases...
    SUPN competitors
    Eton Pharmaceuticals Inc (ETON)
    Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases.
    ETON competitors
    Lifecore Biomedical Inc. (LFCR)
    Lifecore Biomedical, Inc., is an integrated contract development and manufacturing organization in the United States and internationally.
    LFCR competitors
    Kamada (KMDA)
    Kamada Ltd. develops, produces and markets plasma-derived protein therapies for orphan indications. The company is headquartered in Rehovot, Israel.
    KMDA competitors

    Frequently Asked Questions About IRWD

    Who are Ironwood Pharmaceuticals' main competitors?

    The companies most similar to Ironwood Pharmaceuticals include Collegium Pharmaceutical (COLL), Amphastar (AMPH), Phibro Animal Health (PAHC), Pacira BioSciences (PCRX) and Harrow Health (HROW), listed from the closest match.

    Who is Ironwood Pharmaceuticals' biggest competitor?

    BioCryst Pharmaceuticals (BCRX) is the largest of the similar companies at $1.96B; Collegium Pharmaceutical (COLL) is the closest match by business profile, size, sector and industry.

    How does IRWD stock compare with its competitors?

    IRWD's P/E is 5.4x against a peer median of 12.7x; its P/S is 2.0x against a peer median of 2.0x; its net margin is 37.4% against a peer median of 5.9%.

    Which of Ironwood Pharmaceuticals' competitors pays a higher dividend?

    Ironwood Pharmaceuticals pays no dividend. Kamada (KMDA) and Phibro Animal Health (PAHC) have higher forward dividend yields; Kamada (KMDA) has the highest at 2.10%.

    Is Ironwood Pharmaceuticals bigger than its competitors?

    No. Ironwood Pharmaceuticals is 9th by market cap among the 13 companies on this page; the largest is BioCryst Pharmaceuticals (BCRX) at $1.96B.